Stock Picks From The Pros
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Liminal BioSciences (Liminal BioSciences Stock Quote, Chart, News TSX:LMNL) just had a major spike in its share price but Echelon Wealth analyst … [Read more...] about Don’t chase Liminal BioSciences, says Echelon Wealth
Beacon Securities analyst Ahmad Shaath says the new contract wins by Greenlane Renewables (Greenlane Renewables Stock Quote, Chart, News TSXV:GRN) are … [Read more...] about Greenlane Renewables gets bullish new price target at Beacon Securities
The start of a Phase 2 trial is a key step for Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TSX:ONC), says Echelon Wealth Partners … [Read more...] about Oncolytics Biotech has massive upside, says Echelon analyst Loe
Stifel GMP analyst Justin Keywood says investors can expect to see Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) use its … [Read more...] about Ahead of Q1 results, Stifel says buy Knight Therapeutics
Mackie Research analyst André Uddin says investors can expect long-term organic growth and margin improvements from specialty pharma company Medexus … [Read more...] about Medexus Pharma is “significantly undervalued”: Mackie Research
Raymond James analyst Rahul Sarugaser delivered an update to clients on Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News TSX:CRDL) … [Read more...] about Raymond James trims price target on Cardiol Therapeutics
A delay in commercialization is cause for a lowering of the price target for Cardiol Therapeutics (Cardiol Therapeutics Stock Quote, Chart, News … [Read more...] about Cardiol Therapeutics has price target trimmed at AltaCorp Capital
A potential catalyst is coming up for HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News TSX:HLS), according to Stifel GMP analyst Justin … [Read more...] about There’s too much negativity built into HLS Therapeutics share price: Stifel
Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE) has had a turbulent couple of days of trading, but Echelon Wealth Partners … [Read more...] about Antibe Therapeutics is undervalued, Echelon analyst Loe says
Shares of Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News TSX:MDNA) have skyrocketed over the past few months, but there’s … [Read more...] about Medicenna has lots left in the tank, says Bloom Burton
